Sorrento Therapeutics Shares Down 15%; Short Seller Hindenburg Research Publishes 'Sorrento's Pandemic Profiteering: Experts and Former Employees Speak Out on Sensational Claims of Covid-19 Cure'
Benzinga Newsdesk